Research at Pitt finds link to HIV
A discovery in Pittsburgh about how HIV spreads through the human body could help doctors tame the virus in some infected patients, researchers say.
Findings at the University of Pittsburgh Graduate School of Public Health show the disease moves slowly in people whose immune cells are low in cholesterol. That suggests HIV patients might live longer if researchers can regulate cholesterol metabolism in those cells, said lead author Giovanna Rappocciolo.
“We think it's important because it's a very new approach to the study of the HIV infection. I think it could be significant,” said Rappocciolo, an assistant professor in the Department of Infectious Diseases and Microbiology at Pitt.
Her work with department Chairman Charles Rinaldo appears Tuesday in mBio, the journal of the American Society for Microbiology. Funded through the National Institutes of Health, their discovery caps several years of research focused on eight men in the Pittsburgh area.
The men are among 5 percent to 10 percent of the more than 1.1 million people in the United States living with HIV who can stay healthy for seven years — or longer — without conventional therapies, Rappocciolo said.
Those patients had low cholesterol levels inside certain cells that spread HIV in the body, Rappocciolo and several Pitt colleagues found.
Researchers relied on data assembled over 30 years through the Pitt Men's Study, part of the NIH-supported Multicenter AIDS Cohort Study spanning four cities.
“Results like ours are the real payoff of the past three decades of meticulous data and specimen collection,” Rinaldo said in a statement. Rappocciolo said their department has received more than $70 million for research related to AIDS, the final stage of the HIV disease that severely inhibits the immune system.
Rappocciolo stressed her findings do not mean that HIV patients with low-cholesterol diets are safeguarded.
“I don't want people to start thinking that if they have low (blood) cholesterol that they're protected from infection,” Rappocciolo said.
Pitt researchers are investigating whether a genetic predisposition leads to the lower cellular cholesterol levels in some patients.
It's unclear whether doctors can manipulate those levels in patients who might benefit from a decrease. Exploring that possibility could take years of research, Rappocciolo said. She cautioned that cholesterol levels in immune cells do not appear linked to cholesterol in the bloodstream, which is the gauge of conventional cholesterol levels.
Advocates for HIV awareness said the Pitt research follows a string of promising discoveries over several years. Annual HIV mortality rates fell by more than 50 percent from 1987 to 2010, to 2.6 deaths per 100,000 people, according to the federal Centers for Disease Control and Prevention. It estimated 15,529 people with an AIDS diagnosis died in the United States in 2010.
“Every year, the treatments become better and better,” said Emma Brownell, communications director at the Los Angeles-based AIDS Research Alliance of America.
Though researchers have established no definitive HIV cure, a patient in Germany who received stem cell transplants in 2007 and 2008 no longer tests positive for the disease.
A vaccine developed at Oregon Health and Science University appears to have cleared a monkey version of HIV from half the primates treated, according to findings published in September.
“By and large, folks have been able to live longer, go back to work, go back to school, remain active, remain healthy for the most part,” said Oladoyin Desalu, executive director at the AIDS Coalition of Southwestern Pennsylvania. “It's no longer a death sentence.”
Adam Smeltz is a Trib Total Media staff writer. Reach him at 412-380-5676 or firstname.lastname@example.org.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Pens get physical, trade Goc for Blues’ Lapierre
- No cross-checking here: Penguins misspell ‘Sidney’
- Pirates trade Snider to Orioles for minor league pitcher
- Now a Patriot, RB Blount’s thrilled to have moved on from Steelers
- Letang produces 5 assists in return as Penguins defeat Jets, 5-3
- Winfield man is one of a few to attend all 49 Super Bowl games
- Panthers drop heartbreaker in overtime to Virginia Tech
- Cal U professor who died in campus office was lawyer, civil rights leader
- Ex-Steelers QB Batch creates sports medicine startup at Pitt
- New Derry woman charged after mail delivery of 4 pounds of marijuana
- Former Steelers LB Haggans to do time in Westmoreland jail